MedinCell Valuation
| MDCLF Stock | USD 14.00 7.02 100.57% |
At this time, the firm appears to be fairly valued. MedinCell SA secures a last-minute Real Value of $14.45 per share. The latest price of the firm is $14.0. Our model forecasts the value of MedinCell SA from analyzing the firm fundamentals such as Current Valuation of 190.33 M, shares owned by insiders of 47.61 %, and Return On Asset of -0.4 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that MedinCell's price fluctuation is relatively risky at this time. Calculation of the real value of MedinCell SA is based on 3 months time horizon. Increasing MedinCell's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MedinCell pink sheet is determined by what a typical buyer is willing to pay for full or partial control of MedinCell SA. Since MedinCell is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MedinCell Pink Sheet. However, MedinCell's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 14.0 | Real 14.45 | Hype 14.0 |
The real value of MedinCell Pink Sheet, also known as its intrinsic value, is the underlying worth of MedinCell SA Company, which is reflected in its stock price. It is based on MedinCell's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MedinCell's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MedinCell SA helps investors to forecast how MedinCell pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MedinCell more accurately as focusing exclusively on MedinCell's fundamentals will not take into account other important factors: MedinCell Total Value Analysis
MedinCell SA is now expected to have takeover price of 190.33 M with market capitalization of 244.65 M, debt of 16.25 M, and cash on hands of 34.39 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MedinCell fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
190.33 M | 244.65 M | 16.25 M | 34.39 M |
MedinCell Investor Information
About 48.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.88. MedinCell SA had not issued any dividends in recent years. The entity had 50:1 split on the 16th of March 2017. MedinCell SA is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.MedinCell Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MedinCell has an asset utilization ratio of 9.23 percent. This implies that the Company is making $0.0923 for each dollar of assets. An increasing asset utilization means that MedinCell SA is more efficient with each dollar of assets it utilizes for everyday operations.MedinCell Ownership Allocation
MedinCell SA maintains a total of 25.22 Million outstanding shares. MedinCell SA holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.MedinCell Profitability Analysis
The company reported the revenue of 4.09 M. Net Loss for the year was (24.81 M) with profit before overhead, payroll, taxes, and interest of 4.09 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MedinCell's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MedinCell and how it compares across the competition.
About MedinCell Valuation
The pink sheet valuation mechanism determines MedinCell's current worth on a weekly basis. Our valuation model uses a comparative analysis of MedinCell. We calculate exposure to MedinCell's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MedinCell's related companies.It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception mdc-ANG for CNS related treatments mdc-ELK for depression and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. Medincell is traded on OTC Exchange in the United States.
8 Steps to conduct MedinCell's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MedinCell's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MedinCell's valuation analysis, follow these 8 steps:- Gather financial information: Obtain MedinCell's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine MedinCell's revenue streams: Identify MedinCell's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research MedinCell's industry and market trends, including the size of the market, growth rate, and competition.
- Establish MedinCell's growth potential: Evaluate MedinCell's management, business model, and growth potential.
- Determine MedinCell's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MedinCell's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
MedinCell Growth Indicators
Investing in growth stocks can be very risky. If the company such as MedinCell does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 25.1 M | |
| Retained Earnings | -24.8 M |
Complementary Tools for MedinCell Pink Sheet analysis
When running MedinCell's price analysis, check to measure MedinCell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedinCell is operating at the current time. Most of MedinCell's value examination focuses on studying past and present price action to predict the probability of MedinCell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedinCell's price. Additionally, you may evaluate how the addition of MedinCell to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |